Solution

•Download as PPT, PDF•

0 likes•169 views

The document proposes a solution to help with problems in Japan by rebuilding houses and necessary buildings to provide shelter for homeless people and allow those affected to start working again. Donations from each United Nations member could help fund rebuilding homes, schools, and shelters to give people places to live as the area recovers from damage.

Health & Medicine

In Japan ,[object Object],[object Object],[object Object],[object Object]

Recently uploaded

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

basicmodesofventilation2022-220313203758.pdf

aljamhori teaching hospital

These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram. Learning objectives: 1. Define an electrocardiogram (ECG) and electrocardiography 2. Describe how dipoles generated by the heart produce the waveforms of the ECG 3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II) 4. Differentiate between intervals and segments 5. Enlist some common indications for obtaining an ECG Study Resources: 1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition 3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition 4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/ 5. ECG in Medical Practice by ABM Abdullah, 4th edition 6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics

The Normal Electrocardiogram - Part I of II

MedicoseAcademics

The History of Diagnostic Medical imaging

Yahye Mohamed

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

gauripg8

Why invest into infodemic management in health emergencies

Tina Purnat

For any queries ,contact shvmshrm@outlook.com --- ## Introduction to Eating Disorders Welcome to this comprehensive presentation on Eating Disorders, a critical and often misunderstood area of mental health. This presentation is designed to provide in-depth knowledge and insights into the various aspects of eating disorders, making it valuable for both postgraduate medical aspirants preparing for the INI-CET and the general public seeking to understand these complex conditions. ### Objectives: 1. **Understanding Eating Disorders**: Gain a clear understanding of what eating disorders are, their types, and their distinguishing characteristics. 2. **Etiology and Risk Factors**: Explore the underlying causes and risk factors that contribute to the development of eating disorders. 3. **Clinical Features and Diagnosis**: Learn about the clinical features, diagnostic criteria, and the importance of early detection. 4. **Management and Treatment**: Review the current approaches to managing and treating eating disorders, including medical, psychological, and nutritional interventions. 5. **Prevention and Awareness**: Discuss strategies for prevention, early intervention, and increasing awareness about eating disorders. This presentation aims to bridge the gap between academic knowledge and practical understanding, providing you with the tools to recognize, diagnose, and effectively manage eating disorders. Whether you are preparing for a medical exam or seeking to educate yourself or others about these serious conditions, this presentation will equip you with essential information and practical insights. Let's begin our journey into understanding eating disorders and the significant impact they have on individuals and society. --- For any queries ,contact shvmshrm@outlook.com

EATING DISORDERS (Psychiatry-7)by dr Shivam sharma.pptx

Shivam Sharma

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

Savita Shen $i11

TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...

kevinkariuki227

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

hypertensive-disorders-of-pregnancy.pptx

Dr. Rahul Shah

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

AkashGanganePatil1

Contact us if you are interested: Email / Skype : kefaya1771@gmail.com Threema: PXHY5PDH New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH ! Contact me on Threema or skype to start big business!! Hot-sale products: NEW HOT EUTYLONE WHITE CRYSTAL!! 5cl-adba precursor (semi finished ) 5cl-adba raw materials ADBB precursor (semi finished ) ADBB raw materials APVP powder 5fadb/4f-adb Jwh018 / Jwh210 Eutylone crystal Protonitazene (hydrochloride) CAS: 119276-01-6 Flubrotizolam CAS: 57801-95-3 Metonitazene CAS: 14680-51-4 Payment terms: Western Union,MoneyGram,Bitcoin or USDT. Deliver Time: Usually 7-15days Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet. Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details. We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...

GL Anaacs

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

Fundamental of Radiobiology -SABBU.pptx

Sabbu Khatoon

Impact of cancers therapies on the loss in cardiac function, myocardial fffic...

Catherine Liao

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

drwaque

US E-cigarette Summit: Taming the nicotine industrial complex

Clive Bates

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Catherine Liao

Non-Invasive assessment of arterial stiffness in advanced heart failure patie...

Catherine Liao

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

basicmodesofventilation2022-220313203758.pdf

The Normal Electrocardiogram - Part I of II

The History of Diagnostic Medical imaging

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

Why invest into infodemic management in health emergencies

EATING DISORDERS (Psychiatry-7)by dr Shivam sharma.pptx

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...

Ophthalmology Clinical Tests for OSCE exam

hypertensive-disorders-of-pregnancy.pptx

Antiplatelets in IHD, Dose Duration, DAPT vs SAPT

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Fundamental of Radiobiology -SABBU.pptx

Impact of cancers therapies on the loss in cardiac function, myocardial fffic...

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

US E-cigarette Summit: Taming the nicotine industrial complex

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Non-Invasive assessment of arterial stiffness in advanced heart failure patie...

Solution

1. This

2. Is

3. Our

4. Solution

5. To The

6. Problem

9. Our solution is…

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26. People could

27. Start working

28. Again when

29. Their homes

30. And buildings are

31. Rebuilt

32.

33. To get the money

34. For this project

35. We could

36. Get each member

37. Of the United Nations

38. To donate

39. Some money

40.

Solution

Recommended

Recommended

More Related Content

More from whynotts

More from whynotts (19)

Recently uploaded

Recently uploaded (20)

Solution